Medical News

RSS

AcelRx files registration statement with SEC for public offering of common stock

AcelRx Pharmaceuticals, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company.

14 Nov 2010

G20 leaders endorse business-focused economic development plan as Seoul summit closes

The G20 summit in Seoul, South Korea, ended Friday with leaders issuing a communique that endorsed the multi-year Seoul Development Consensus for Shared Growth, Xinhua reports

14 Nov 2010

Acne, acne medicine and mental health: Study

Acne drug Accutane (isotretinoin) has been plagued by serious controversies with some linking it to suicidal tendencies. Now the latest research finds that severe acne itself increases the risk for suicidal thoughts and actions, raising more questions about the role of the drug, if any, in suicide.

14 Nov 2010

30 seconds to predict possibility of Alzheimer’s disease

It could take a mere 30 seconds to spot signs of Alzheimer’s disease in 40 year-olds in the near future say scientists who are developing a new diagnostic test. Usually Alzheimer’s disease is detected much later in life after the symptoms begin to appear.

14 Nov 2010

Lawsuits scaring Australian doctors away: Study

The latest study shows that Australian doctors are now so afraid of being sued by patients that one third are considering giving up medicine. The study looked at nearly 3,000 specialists, general practitioners and trainees. Alarmingly 32% are considering reducing their work hours and 40 per cent are considering early retirement.

14 Nov 2010

Australian epidemics research programme to be disbanded

The Australian Federal Government scrapped the funding to the Australian National University’s Master of Applied Epidemiology (MAE) program. This group helps Australia’s response to major disease outbreak and will be disbanded at the end of next year. According to Emeritus Professor Robert Douglas who founded this program, this has been responsible for Australia’s response to serious epidemic outbreaks in the past.

14 Nov 2010

Heart break fatal: Study

In the latest research scientists have found that it is really possible to die of a broken heart. The study shows that the immense grief of losing a loved one means that many people die within three years of their husband or wife.

14 Nov 2010

Pennsylvania health giant reports $93 million profit as outpatient demand surges

Pittsburgh Tribune-Review: "Health giant UPMC will add 815 new full-time jobs through next June, officials announced yesterday after posting a strong first-quarter income. More than half of the jobs -- or about 430 -- will be throughout UPMC's network of 20 hospitals. They include physicians, nurses, food service workers, housekeepers and administrators, said Rob DeMichiei, senior vice president and chief financial officer.

12 Nov 2010

Research roundup: Doctors' industry ties; Patient safety and residents' hours; Designing a medical home

Archives of Internal Medicine: Physician Professionalism And Changes in Physician-Industry Relationships From 2004 to 2009 -"During the last 6 years a number of efforts have aimed to reduce, and in some cases eliminate, certain types of physician-industry relationships (PIRs)," including policies "that forbid physicians from accepting samples and receiving food and beverages in offices, limiting company representatives' access to physicians' offices and clinical areas, and banning faculty participation in speaker bureaus and other forms of promotional activity," write the authors.

12 Nov 2010

Derma Sciences net sales for third quarter 2010 increase 17% to $15,096,134

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and nine months ended September 30, 2010.

12 Nov 2010

States' woes spur Medicaid drop-out talk

This story, a collaboration between Kaiser Health News' Marilyn Werber Serafini, the Kaiser Family Foundation's Robin Toner Distinguished Fellow, and the Texas Tribune's Emily Ramshaw, reports on Medicaid developments: "A week after newly emboldened Republicans in the Texas Legislature floated a radical cost-saving proposal — opting out of the federal Medicaid program — health care experts, economists and think tanks are trying to determine just how serious they are, and if it would even be possible" (Ramshaw and Serafini, 11/12).

12 Nov 2010

Changes to flexible spending accounts raise concerns

NPR reports on the upcoming change to flexible spending accounts, when "you'll no longer be able to set aside pretax dollars in that account to use for medicines bought without a doctor's prescription," and looks at the "loophole" that may allow consumers to use FSA dollars on over-the-counter medication if they obtain a prescription for it.

12 Nov 2010

Pernix third quarter net sales increase 33% to $7,779,000

Pernix Therapeutics Holdings, Inc., an integrated specialty pharmaceutical company primarily focused on the pediatric market, today announced results for the three and nine months ended September 30, 2010.

12 Nov 2010

Clinical trial results of Threshold's TH-302 hypoxia-activated prodrug presented at 16th CTOS annual meeting

Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 16th Annual Connective Tissue Oncology Society (CTOS) Meeting taking place in Paris, France from November 11 to 13, 2010.

12 Nov 2010

SANUWAVE third quarter revenues increase to $278,000

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, today reported financial results for the three and nine months ended September 30, 2010 and provided a business update.

12 Nov 2010

Hana Biosciences announces financial results of third quarter 2010

Hana Biosciences, Inc., a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the three and nine months ended September 30, 2010, and provided a corporate update.

12 Nov 2010

Freedom Meditech announces clinical study results of I-SugarX non-invasive glucose monitoring system

Freedom Meditech, Inc., the developer of non-invasive, ophthalmic-based products to detect and manage diabetes, today announced results of a clinical study that showed a high correlation between low to high blood glucose levels and non-invasive glucose measurements in the eye in a live animal model.

12 Nov 2010

Nile third quarter net loss decreases to $1.8 million

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for therapeutics for cardiovascular disease, today announced its third quarter financial results for 2010.

12 Nov 2010

Neurologix third quarter net loss decreases to $2.3 million

Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system ("CNS"), today reported its financial results for the three and nine months ended September 30, 2010.

12 Nov 2010

Denial is top reason for patients to delay treatment for skin cancer

If detected early, nonmelanoma skin cancers (primarily basal cell and squamous cell carcinomas, the two most common forms of skin cancer) can be easily treated. But when left untreated, these skin cancers can grow and even spread, causing considerably more harm than if they were treated upon initial detection. Now, a new study finds that denial is the top reason why patients delay seeking treatment for skin cancer and shows that this delay results in larger, more serious, skin cancers.

12 Nov 2010